NO20001087L - Medikament for forlengelse av muskelfunksjon eller behandling av muskelforstyrrelser eller -sykdommer - Google Patents
Medikament for forlengelse av muskelfunksjon eller behandling av muskelforstyrrelser eller -sykdommerInfo
- Publication number
- NO20001087L NO20001087L NO20001087A NO20001087A NO20001087L NO 20001087 L NO20001087 L NO 20001087L NO 20001087 A NO20001087 A NO 20001087A NO 20001087 A NO20001087 A NO 20001087A NO 20001087 L NO20001087 L NO 20001087L
- Authority
- NO
- Norway
- Prior art keywords
- diseases
- treatment
- muscle
- medication
- extension
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Neurology (AREA)
- Physical Education & Sports Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Fodder In General (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9703191A SE512531C2 (sv) | 1997-09-04 | 1997-09-04 | Användning av åtminstone en typ av xantofyller för framställning av ett läkemedel för profylaktisk och/eller terapeutisk förbättring av muskelfunktionsdurationen hos däggdjur och/eller behandling av muskelstörningar eller - sjukdomar hos däggdjur |
PCT/SE1998/001526 WO1999011251A1 (fr) | 1997-09-04 | 1998-08-26 | Medicament pour l'amelioration de la duree de la fonction musculaire ou le traitement de troubles ou de maladies musculaires |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20001087L true NO20001087L (no) | 2000-03-02 |
NO20001087D0 NO20001087D0 (no) | 2000-03-02 |
Family
ID=20408142
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20001087A NO20001087D0 (no) | 1997-09-04 | 2000-03-02 | Medikament for forlengelse av muskelfunksjon eller behandling av muskelforstyrrelser eller -sykdommer |
Country Status (13)
Country | Link |
---|---|
US (1) | US6245818B1 (fr) |
EP (1) | EP1011653B1 (fr) |
JP (1) | JP3660244B2 (fr) |
AT (1) | ATE230985T1 (fr) |
AU (1) | AU727349B2 (fr) |
CA (1) | CA2299366C (fr) |
DE (1) | DE69810784T2 (fr) |
DK (1) | DK1011653T3 (fr) |
ES (1) | ES2191329T3 (fr) |
NO (1) | NO20001087D0 (fr) |
PL (1) | PL338982A1 (fr) |
SE (1) | SE512531C2 (fr) |
WO (1) | WO1999011251A1 (fr) |
Families Citing this family (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7078040B2 (en) | 2000-03-27 | 2006-07-18 | Fuji Chemical Industry Co., Ltd. | Method of inhibiting the expression of inflammatory cytokines and chemokines |
SE0001071D0 (sv) * | 2000-03-27 | 2000-03-27 | Astacarotene Ab | Method of inhibiting the expression of inflammatory cytokines and chemokines |
SE0003186D0 (sv) * | 2000-09-07 | 2000-09-07 | Astrazeneca Ab | New process |
US6900324B2 (en) | 2000-09-07 | 2005-05-31 | Astrazeneca Ab | Process for preparing a substituted imidazopyridine compound |
US20050143475A1 (en) * | 2002-07-29 | 2005-06-30 | Lockwood Samuel F. | Carotenoid analogs or derivatives for the inhibition and amelioration of ischemic reperfusion injury |
US20050049248A1 (en) * | 2002-07-29 | 2005-03-03 | Lockwood Samuel Fournier | Carotenoid ether analogs or derivatives for controlling C-reactive protein levels |
US7345091B2 (en) | 2002-07-29 | 2008-03-18 | Cardax Pharmaceuticals, Inc. | Carotenoid ether analogs or derivatives for the inhibition and amelioration of disease |
US20050004235A1 (en) * | 2002-07-29 | 2005-01-06 | Lockwood Samuel Fournier | Carotenoid analogs or derivatives for the inhibition and amelioration of liver disease |
US7521584B2 (en) * | 2002-07-29 | 2009-04-21 | Cardax Pharmaceuticals, Inc. | Carotenoid analogs or derivatives for the inhibition and amelioration of disease |
US7723327B2 (en) | 2002-07-29 | 2010-05-25 | Cardax Pharmaceuticals, Inc. | Carotenoid ester analogs or derivatives for the inhibition and amelioration of liver disease |
US20050148517A1 (en) * | 2002-07-29 | 2005-07-07 | Lockwood Samuel F. | Carotenoid ether analogs or derivatives for controlling connexin 43 expression |
US20050059659A1 (en) * | 2002-07-29 | 2005-03-17 | Lockwood Samuel Fournier | Carotenoid analogs or derivatives for controlling C-reactive protein levels |
US7763649B2 (en) | 2002-07-29 | 2010-07-27 | Cardax Pharmaceuticals, Inc. | Carotenoid analogs or derivatives for controlling connexin 43 expression |
US7320997B2 (en) | 2002-07-29 | 2008-01-22 | Cardax Pharmaceuticals, Inc. | Pharmaceutical compositions including carotenoid ester analogs or derivatives for the inhibition and amelioration of disease |
US20050059635A1 (en) * | 2002-07-29 | 2005-03-17 | Lockwood Samuel Fournier | Carotenoid ester analogs or derivatives for controlling C-reactive protein levels |
CA2495167C (fr) | 2002-07-29 | 2018-08-21 | Hawaii Biotech, Inc. | Analogues de carotenoides structuraux pour l'inhibition et la reduction de maladie |
US7375133B2 (en) * | 2002-07-29 | 2008-05-20 | Cardax Pharmaceuticals, Inc. | Pharmaceutical compositions including carotenoid ether analogs or derivatives for the inhibition and amelioration of disease |
US20050026874A1 (en) * | 2002-07-29 | 2005-02-03 | Lockwood Samuel Fournier | Carotenoid ether analogs or derivatives for the inhibition and amelioration of liver disease |
AU2002329108A1 (en) * | 2002-09-03 | 2004-03-29 | Centro De Investigacion En Alimentacion Y Desarrollo A.C. | Method of preparing chitosan microcapsules of astaxanthin and product thus obtained |
US8034372B2 (en) * | 2003-03-05 | 2011-10-11 | Nestec, Ltd. | Dietary supplement for athletic pets |
US7727752B2 (en) | 2003-07-29 | 2010-06-01 | Life Technologies Corporation | Kinase and phosphatase assays |
EP1974730A1 (fr) * | 2003-11-03 | 2008-10-01 | AstraZeneca AB | Dérivés d'imidazo[1,2-a]pyridine pour l'utilisation dans le traitement des troubles du sommeil provoqués par un reflux gastro-oesophagien silencieux |
SE0303451D0 (sv) * | 2003-12-18 | 2003-12-18 | Astrazeneca Ab | New compounds |
EP2653157B1 (fr) * | 2004-02-04 | 2016-08-03 | Fuji Chemical Industry Co., Ltd. | Astaxanthine pour l'amélioration de l'atrophie des muscles |
EP1750723A1 (fr) | 2004-04-14 | 2007-02-14 | Hawaii Biotech, Inc. | Analogues ou derives de carotenoide pour inhiber et reduire l'inflammation |
US20060058269A1 (en) * | 2004-04-14 | 2006-03-16 | Lockwood Samuel F | Carotenoid analogs or derivatives for the inhibition and amelioration of inflammation |
US20060111580A1 (en) * | 2004-10-01 | 2006-05-25 | Lockwood Samuel F | Methods for the synthesis of chiral dihydroxy ketone intermediates useful for the chiral synthesis of carotenoids |
JP5196708B2 (ja) * | 2005-02-04 | 2013-05-15 | 富士化学工業株式会社 | アスタキサンチン及び/又はそのエステルを有効成分とする筋萎縮改善剤及び飲食物 |
EP1874289A2 (fr) | 2005-03-29 | 2008-01-09 | Cardax Pharmaceuticals, Inc. | Reduction de l'activation du complement et de l'inflammation dans une lesion tissulaire a l'aide de carotenoides, d'analogues de carotenoides ou de derives de carotenoides |
US20090297492A1 (en) * | 2008-05-30 | 2009-12-03 | Yamaha Hatsudoki Kabushiki Kaisha | Method for Improving Cognitive Performance |
US10867701B1 (en) | 2010-06-28 | 2020-12-15 | Heinrich Anhold | System and method for optimizing patient-specific intervention strategies using point of care diagnostics |
JP5924592B2 (ja) * | 2013-04-30 | 2016-05-25 | 株式会社ダイセル | 抗疲労用組成物 |
CN112057420A (zh) * | 2020-09-21 | 2020-12-11 | 中国科学院烟台海岸带研究所 | 一种虾青素喷剂及其制备方法、使用方法 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2558372B1 (fr) * | 1984-01-25 | 1987-08-07 | Oreal | Composition medicamenteuse pour le traitement de l'acne |
JP2619491B2 (ja) | 1988-08-11 | 1997-06-11 | サントリー株式会社 | アスタキサンチン含有組成物 |
JPH0665033A (ja) * | 1992-08-11 | 1994-03-08 | Lion Corp | 口腔用組成物 |
IL110139A0 (en) | 1993-06-28 | 1994-10-07 | Howard Foundation | Pharmaceutically-active antioxidants |
US5886053A (en) * | 1995-02-03 | 1999-03-23 | Basf Aktiengesellschaft | Use of carotenoids for producing drugs for the treatment of dermatoses |
JPH09124470A (ja) * | 1995-10-26 | 1997-05-13 | Suntory Ltd | 抗ストレス組成物 |
-
1997
- 1997-09-04 SE SE9703191A patent/SE512531C2/sv not_active IP Right Cessation
-
1998
- 1998-08-26 AT AT98943128T patent/ATE230985T1/de not_active IP Right Cessation
- 1998-08-26 CA CA002299366A patent/CA2299366C/fr not_active Expired - Lifetime
- 1998-08-26 DE DE69810784T patent/DE69810784T2/de not_active Expired - Lifetime
- 1998-08-26 EP EP98943128A patent/EP1011653B1/fr not_active Expired - Lifetime
- 1998-08-26 PL PL98338982A patent/PL338982A1/xx unknown
- 1998-08-26 DK DK98943128T patent/DK1011653T3/da active
- 1998-08-26 AU AU90989/98A patent/AU727349B2/en not_active Ceased
- 1998-08-26 JP JP2000508354A patent/JP3660244B2/ja not_active Expired - Lifetime
- 1998-08-26 WO PCT/SE1998/001526 patent/WO1999011251A1/fr active IP Right Grant
- 1998-08-26 ES ES98943128T patent/ES2191329T3/es not_active Expired - Lifetime
- 1998-08-26 US US09/485,704 patent/US6245818B1/en not_active Expired - Lifetime
-
2000
- 2000-03-02 NO NO20001087A patent/NO20001087D0/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
SE9703191D0 (sv) | 1997-09-04 |
PL338982A1 (en) | 2000-12-04 |
WO1999011251A1 (fr) | 1999-03-11 |
ATE230985T1 (de) | 2003-02-15 |
CA2299366A1 (fr) | 1999-03-11 |
SE512531C2 (sv) | 2000-03-27 |
DK1011653T3 (da) | 2003-05-26 |
EP1011653B1 (fr) | 2003-01-15 |
EP1011653A1 (fr) | 2000-06-28 |
US6245818B1 (en) | 2001-06-12 |
AU9098998A (en) | 1999-03-22 |
ES2191329T3 (es) | 2003-09-01 |
AU727349B2 (en) | 2000-12-14 |
DE69810784D1 (de) | 2003-02-20 |
JP2001514215A (ja) | 2001-09-11 |
SE9703191L (sv) | 1999-03-05 |
DE69810784T2 (de) | 2003-11-13 |
JP3660244B2 (ja) | 2005-06-15 |
NO20001087D0 (no) | 2000-03-02 |
CA2299366C (fr) | 2008-04-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20001087L (no) | Medikament for forlengelse av muskelfunksjon eller behandling av muskelforstyrrelser eller -sykdommer | |
HK1031197A1 (en) | Osmotic dosage form comprising first and second coats | |
IS4516A (is) | Nýtt lyfjaform | |
ATE515265T1 (de) | Vitamin d und dessen analoge zur behandlung vom tumoren und anderen hyperproliferativen erkrankungen | |
ATE234602T1 (de) | Verabreichungsform zur abgabe von steigenden wirkstoffdosen | |
ES2162615T3 (es) | Metodo para tratar o prevenir diabetes de tipo 1 mediante la administracion oral de insulina. | |
ATE306931T1 (de) | Unterdrückung von veränderungen in zusammenhang mit beta-amyloid bei alzheimer | |
AU3040995A (en) | Treatment of autoimmune diseases by oral administration of autoantigens | |
ATE321529T1 (de) | Dosierungsform für eine verzögerte und zunehmende wirkstoffsfreisetzung | |
IL195723A (en) | Use of p53 inhibitors for the preparation of medicament | |
GEP20043216B (en) | Orally Administered Controlled Drug Delivery System | |
BR9811086A (pt) | Utilização de preparados de eritropoietina e ferro, processo para a produção de um preparado de combinação farmacêutica e embalagem unitária farmacêutica | |
NO890186L (no) | Fremgangsmaate for fremstilling av en avgivelses- og/ellerdoseringsform for legemiddelaktive stoffer. | |
FI913100A0 (fi) | Farmaceutiska preparat. | |
DE69200711D1 (de) | Pharmazeutische Zusammensetzungen enthaltend Fluticasonpropionat und Oxikonazol oder dessen Salz zur lokalen Anwendung. | |
ATE234082T1 (de) | Adenosin enthaltendes arzneimittel | |
DE3787477D1 (de) | Nasal applizierbares Arzneimittel, Verfahren zu seiner Herstellung und seine Verwendung. | |
AR002724A1 (es) | Peptido purificado fisiologicamente activo, sales de adicion de acido y sales de bases de dicho peptido, formas de dosificacion oral, intra-traqueal ynasal que comprenden a dicho peptido, formulacion farmaceutica que comprende a dicho peptido, usos de dicho peptido, metodo para la preparacion de dicha | |
WO1999018941A3 (fr) | MODULATEURS DE CANAL I¿h? | |
DK0559145T3 (da) | Lægemiddel til truende abort | |
EE9900346A (et) | Viljatusevastane ja viljastumisvõimet tõstev ravim | |
WO1998036778A8 (fr) | Administration entretenue de medicaments et compositions convenant a cet effet | |
BR9710629A (pt) | Composi-Æo farmac-utica processo para sua prepara-Æo composto para utiliza-Æo como agente terap-utico e utiliza-Æo e utiliza-Æo de um composto | |
ES2161809T3 (es) | Uso de factor proliferativo osteoblastico. | |
WO2001012166A3 (fr) | Traitement ameliore de troubles physiques aigus du systeme nerveux central |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |